Lack of correlation between EBV serology and presence of EBV in the Hodgkin and Reed-Sternberg cells of patients with Hodgkin's disease

International Journal of Cancer

Volumn 72, Issue 3, 1997, Pages 394-397

  Enblad, Gunilla ^a   Sandvej, Kristian ^b   Lennette, Evelyne ^c   Sundström, Christer ^a   Klein, Georg ^d   Glimelius, Bengt ^a   Pallesen, Gorm ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b AARHUS UNIVERSITY   (Denmark)

^c Virolab Inc   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; EPSTEIN BARR VIRUS; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REED STERNBERG CELL; SEROLOGY;

ADULT; ANTIBODIES, VIRAL; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FEMALE; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOCYTES; MALE; PROGNOSIS; REED-STERNBERG CELLS; RIBOSOMAL PROTEINS; RNA-BINDING PROTEINS; VIRAL MATRIX PROTEINS;

EID: 0030744416     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970729)72:3<394::AID-IJC3>3.0.CO;2-K     Document Type: Article

References (27)

1. AUDOUIN, J., DIEBOLD, J. and PALLESEN, G., Frequent expression of Epstein-Barr-virus latent membrane protein-1 in tumour cells of Hodgkin's disease in HIV-positive patients. J. Pathol., 167, 381-383 (1992).
2. BJÖRKHOLM, M., HOLM, G. and MELLSTEDT, H., Immunocompetence in patients with Hodgkin's disease. In: M.J. Lacher and J.R. Redman (eds.), Hodgkin's disease. The consequences of survival, pp. 112-150. Lea and Febiger, Philadelphia (1990).
3. CARBONE, P.P., KAPLAN, H.S., MUSSHOFF, K., SMITHERS, D.W. and TUBIANA, M., Report on the committee on Hodgkin's disease staging. Cancer Res., 31, 1960-1961 (1971).
4. CORREA, P. and O'CONOR, G.T., Epidemiologic patterns of Hodgkin's disease. Int. J. Cancer, 8, 192-201 (1979).
5. DE THÉ, G., The epidemiology of Burkitt's lymphoma: evidence for a causal association with Epstein-Barr virus. Epidemiol. Rev., 1, 32-54 (1979).
6. ENBLAD, G., GLIMELIUS, B. and SUNDSTRÖM, C. Treatment outcome in Hodgkin's disease in patients above the age of 60: a population-based study. Ann. Oncol., 2, 297-302 (1991).
7. FRISAN, T. and 15 OTHERS, Local suppression of Epstein-Barr-virus (EBV)specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease. Blood, 86, 1493-1501 (1995).
8. GLIMELIUS, B., ENBLAD, G., KÄLKNER, M., GUSTAVSSON, A., JAKOBSSON, M., BRANEHÖG, I., LENNER, P. and BJÖRKHOLM, M,. Treatment of Hodgkin's disease: The Swedish National Care Program experience. Leukemia Lymphoma, 21, 71-78 (1996).
9. HAMILTON-DUTOIT, S.J., RAPHAÉL, M., AUDOUIN, J., DIEBOLD, J., LISSE, I., PEDERSEN, C., OKSENHENDLER, E., MAKELLE, L. and PALLESEN, G., In situ demonstration of Epstein-Barr-virus small RNAs (EBER 1) in acquired-immunodeficiency-syndrome-related lymphomas: correlation with tumor morphology and primary site. Blood, 82, 619-624 (1993).
10. JARRRTT, R.F., GALLAGHER, A., JONES, D.B., ALEXANDER, F.E., KRAJEWSKI, A.S., KELSEY, A., ADAMS, J., ANGUS, B., GLEDHILL, S., WRIGHT, D.H., CARTWRIGHT, R.A. and ONIONS, D.E., Detection of Epstein-Barr-virus genomes in Hodgkin's disease: relation to age. J. clin. Pathol., 44, 844-848 (1991).
11. JOHANSSON, B., KLEIN, G., HENLE, W. and HENLE, G., Epstein-Barr-virus(EBV)-associated antibody patterns in malignant lymphoma and leukemia. Hodgkin's disease. Int. J. Cancer, 6, 450-462 (1970).
12. KLEIN, G., Epstein-Barr-virus-carrying cells in Hodgkin's disease. Blood, 80, 299-301 (1992).
13. LENNETTE, E.T., RYMO, L., YADAV, M., MASUCCI, G., MERK, K., TIMAR, L. and KLEIN, G., Disease-related differences in antibody patterns against EBV-encoded nuclear antigens EBNA 1, EBNA 2 and EBNA 6. Europ. J. Cancer, 29, 1584-1589 (1993).
14. LEVINE, P.H., PALLESEN, G., EBBESEN, P., HARRIS, N., EVANS, A.S. and MUELLER, N., Evaluation of Epstein-Barr-virus-antibody patterns and detection of viral markers in the biopsies of patients with Hodgkin's disease. Int. J. Cancer, 59, 48-50 (1994).
15. LEVINE, P.H., STEMMERMAN, G., LENNETTE, E.T., HILDESHEIM, A., SHIBATA, D, and NOMURA, A., Elevated antibody titers to Epstein-Barr virus prior to the diagnosis of Epstein-Barr-virus-assoeiated gastric adenocarcinoma. Int. J. Cancer, 60, 642-644 (1995).
16. LUKES, R.J., CRAVER, L.F., HALL, T.C., RAPPAPORT, H. and RUBEN, P., Report of the Nomenclature Committee. Cancer Res., 26, 1311 (1966).
17. MASUCCI, G., MELLSTEDT, H., HENLE, G., HENLE, W., RYMO, L. MASUCCI, M., ERNBERG, I. and KLEIN, G., Relationship between clinical stage, histopathology and antibody titers against the second Epstein-Barr-virus nuclear antigen (EBNA-2) in non-Hodgkin's lymphoma patients. Int. J. Cancer, 43, 1017-1021 (1989).
18. MERK, K., LENNETTE, E.T., HOLM, G., JOHANSSON, B., MASUCCI, G., KLEIN, G, and BJÖRKHOLM, M., Antibodies to Epstein-Barr virus in relation to clinical characteristics of untreated patients with Hodgkin's disease. In: An epidemiological approach to the etiology of Hodgkin's disease. Thesis. By Karl Merk. Department of Oncology, Karolinska Institute, Stockholm (1992).
19. MUELLER, N., Epidemiological studies assessing the role of Bpstein-Barr virus in Hodgkin's disease. Yale J. Biol. Med., 60, 321-327 (1987).
20. MUELLER, N., An epidemiologist's view of the new molecular findings in Hodgkin's disease. Ann. Oncol. 2 (Suppl. 2). 23-28 (1991).
21. MUELLER, N., EVANS, A., HARRIS, N.L., COSTOCK, G.W., JELLUM, E., MAGNUS, K., ORENTREICH, N., POLK, B.F. and VOGELMAN, J., Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis. New Engl. J. Med., 320, 689-695 (1989).
22. PALLESEN, G., HAMILTON-DUTOIT, S.J., ROWE, M. and YOUNG, L.S., Expression of Epstein-Barr-virus latent gene products in tumour cells in Hodgkin's disease. Lancet, 337, 320-322 (1991).
23. PALLESEN, G., HAMILTON-DUTOIT, S.J. and ZHOU, X.G., The association of Epstein-Barr virus (EBV) with T-cell lymphoproliferations and Hodgkin's disease: two new developments in the EBV field. Advanc. Cancer Res., 62, 179-239 (1993).
24. SERRAINO, D., CARBONE, A., FRANCESCHI, S. and TIRELLI, U., Increased frequency of lymphocyte depletion and mixed cellularity sub-types of Hodgkin's disease in HIV-infectcd patients. Europ. J. Cancer, 29A, 1948-1950 (1993).
25. STEIN, H., HERBST, H., ANAGNOSTOPOLLOS, I., NIEDOBITEK, G., DALLENBACH, F. and KRATZCH, H.-C., The nature of the Hodgkin and Reed-Sternberg cells, their association with EBV, and their relationship to anaplastic large-cell lymphoma. Ann. Oncol., 2 (Suppl 2), 33-38 (1991).
26. VESTLEV, P.M., PALLESEN, G., SANDVEJ, K., HAMILTON-DUTOIT, S.J. and BENDTZEN, S.M., Prognosis of Hodgkin's disease is not influenced by Epstein-Barr-virus latent membrane protein. Int. J. Cancer. 51, 1-3 (1992).
27. ZHOU, X.G., HAMILTON-DUTOIT, S.J., YAN, Q.H. and PALLESEN, G., The association between Epstein-Barr virus and Chinese Hodgkin's disease. Int. J. Cancer. 55, 359-363 (1993).